How breast milk wards off severe intestinal disease in premature babies

Image
ANI Washington
Last Updated : Apr 23 2015 | 10:22 AM IST

A new study conducted on mice has revealed how breast milk protects premature babies from severe intestinal disease.

A team of scientists led by Johns Hopkins pediatric surgeon-in-chief David Hackam, M.D., Ph.D., showed breast milk works to ward off the development of necrotizing enterocolitis (NEC), a devastating intestinal disorder that affects 12 percent of premature babies and claims the lives of one in four of those who have it.

The research revealed that a substance found in animal and human breast milk called epidermal growth factor, or EGF, blocks the activation of a protein responsible for unlocking the damaging immune cascade that culminates in NEC, a disease marked by the swift and irreversible death of intestinal tissue that remains one of the most-challenging-to-treat conditions.

New therapies are acutely needed for NEC, the research team says, because current treatment is limited to surgical removal of the dying, or necrotizing, portions of a baby's intestine. The approach halts further necrosis and can save a baby's life, but it often leaves infants with insufficient intestine and puts them at risk for long-term complications, such as short bowel syndrome, which requires feeding support for life due to the intestines' decreased ability to absorb enough nutrients. Pinpointing EGF as a key factor in NEC should offer new therapeutic targets that obviate or reduce the need for drastic surgery, the researchers say.

Study author Misty Good, M.D., at the University of Pittsburgh Medical Center Taken said that together the findings show that EGF was a key factor present in breast milk that prevents the onset of NEC in two ways: EGF prevents intestinal cells from dying while at the same time restoring the cell growth that promotes gut healing. Importantly, their experiments stressed on the importance of providing breast milk to premature babies to prevent this deadly disease.

The study is published in the journal Mucosal Immunology.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 23 2015 | 10:05 AM IST

Next Story